![Erik Strömqvist](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erik Strömqvist
Directeur/Membre du Conseil chez
XVIVO PERFUSION AB
Fortune : 52 463 $ au 31/05/2026
Profil
Currently, Erik Strömqvist is Chairman at MedTrace Pharma AS since 2024, Independent Director at Xvivo Perfusion AB since 2023, Director at Atley Solutions AB since 2021, and Chief Operating Officer at Swiss Nuclides AG.
Formerly, Mr. Strömqvist was Independent Director at Studsvik AB from 2021 to 2026, Director at Celcibus AB from 2020 to 2023, President at Swiss Nuclides Sweden AB, and General Manager-Cyclotrons & TRACERcenter at GE Healthcare AB from 2009 to 2020.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
XVIVO PERFUSION AB 0,01% | 24/10/2025 | 1 750 ( 0,01% ) | 52 463 $ | 31/05/2026 |
Postes actifs de Erik Strömqvist
| Sociétés | Poste | Début |
|---|---|---|
| XVIVO PERFUSION AB | Directeur/Membre du Conseil | 01/01/2023 |
Swiss Nuclides AG
 Swiss Nuclides AG Hospital/Nursing ManagementHealth Services Provides cancer patients diagnostics and radiopharmaceutical therapy treatment services | Directeur des opérations | - |
Atley Solutions AB
 Atley Solutions AB Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Directeur/Membre du Conseil | 01/06/2021 |
MedTrace Pharma AS
 MedTrace Pharma AS Medical SpecialtiesHealth Technology Provides medical devices for hospital departments | Président | 01/01/2024 |
Anciens postes connus de Erik Strömqvist
| Sociétés | Poste | Fin |
|---|---|---|
| STUDSVIK AB | Directeur/Membre du Conseil | 21/01/2026 |
Celcibus AB
 Celcibus AB Electronic Equipment/InstrumentsElectronic Technology Manufactures hydrogen fuel cells | Directeur/Membre du Conseil | 01/06/2023 |
GE Healthcare AB
 GE Healthcare AB Pharmaceuticals: MajorHealth Technology Wholesales and distributes pharmaceutical products | Corporate Officer/Principal | 01/06/2020 |
Swiss Nuclides Sweden AB | President | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Studsvik AB
 Studsvik AB Miscellaneous Commercial ServicesCommercial Services Provides decommissioning and radiation protection services | Commercial Services |
GE Healthcare AB
GE Healthcare AB Pharmaceuticals: MajorHealth Technology Wholesales and distributes pharmaceutical products | Health Technology |
Xvivo Perfusion AB
 Xvivo Perfusion AB Medical SpecialtiesHealth Technology Operates as a medical technology company which develops solutions for organ, tissue, and cell preservation | Health Technology |
MedTrace Pharma AS
MedTrace Pharma AS Medical SpecialtiesHealth Technology Provides medical devices for hospital departments | Health Technology |
Atley Solutions AB
Atley Solutions AB Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Celcibus AB
Celcibus AB Electronic Equipment/InstrumentsElectronic Technology Manufactures hydrogen fuel cells | Electronic Technology |
Swiss Nuclides AG
Swiss Nuclides AG Hospital/Nursing ManagementHealth Services Provides cancer patients diagnostics and radiopharmaceutical therapy treatment services | Health Services |
Swiss Nuclides Sweden AB |
